Why the study?
An analysis of modern international guidelines for the treatment of arterial hypertension in pregnant women was needed to summarize current recommendations.
Current international guidelines consistently recommend labetalol, nifedipine, and methyldopa as first-line antihypertensive therapies in pregnant women, alongside aspirin for preeclampsia prevention.
Reinforces guideline consensus on pregnancy hypertension management; leaves open need for comparative RCTs on agents and outcomes.
The purpose of the work – to carry out an analysis of modern international guidelines forthe treatment of arterial hypertension in pregnant women.Conclusions. According to the most recommendations, labetalol, nifedipine, andmethyldopa in solid dosage form are the drugs of the first line of therapy. Labetalol(intravenous), hydralazine (intravenous or intramuscular) and immediate- releasenifedipine are used in emergency settings. For the purpose of pharmacocorrection ofpreeclampsia, the appointment of acetylsalicylic acid is relevant, the dose range of thedrug ranges from 75 to 162 mg/day before bedtime.
No takes yet. Share an insight, caveat, or question.
Bukataru et al. (2024) conducted a review in Arterial hypertension in pregnancy. Antihypertensive therapy was evaluated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: